Back to UBS Group AG UBS Group AG

RCELRCEL
25 quarters

Position history for UBS Group AGUBS Group AG's holdings in AVITA MEDICAL INC

UBS Group AG holds 84,033 shares of RCEL (AVITA MEDICAL INC), worth $347,056 as of 2026-Q2. The position was increased (+34.5% shares).

Current Value

$347,056

Current Shares

84,033

Total Value Change

+$312,056

Total Shares Change

+82,874

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
84,033
+34.5%
$347,0560.0%$4.13
21
2026-Q1
Decreased
62,454
-30.8%
$231,0790.0%$4.81
0
2025-Q4
Increased
90,309
+19.8%
$311,5660.0%$3.45
28
2025-Q3
Decreased
75,400
-81.6%
$385,2940.0%$5.37
0
2025-Q2
Increased
409,799
+18.9%
$2.2M0.0%$5.45
31
2025-Q1
Increased
344,728
+168.0%
$2.8M0.0%$8.73
42
2024-Q4
Increased
128,630
+622.4%
$1.6M0.0%$13.21
41
2024-Q3
Increased
17,806
+4.0%
$190,8800.0%$10.74
16
2024-Q2
Decreased
17,120
-66.8%
$135,5900.0%$7.92
0
2024-Q1
Increased
51,516
+157.5%
$825,8020.0%$16.03
40
2023-Q4
Increased
20,007
+56.9%
$274,4960.0%$13.72
33
2023-Q3
Decreased
12,749
-27.1%
$186,2630.0%$14.61
0
2023-Q2
Increased
17,478
+190.9%
$297,3000.0%$17.48
38
2023-Q1
Increased
6,008
+727.5%
$83,9320.0%$13.35
24
2022-Q4
Increased
726
+190.4%
$4,7920.0%$6.60
16
2022-Q3
Decreased
250
-80.4%
$1,0000.0%$5.49
0
2022-Q2
Decreased
1,273
-9.7%
$6,0000.0%$5.05
0
2022-Q1
Decreased
1,409
-96.2%
$13,0000.0%$8.56
0
2021-Q4
Increased
37,229
+130.0%
$445,0000.0%$11.76
39
2021-Q3
Increased
16,187
+1248.9%
$287,0000.0%$17.65
38
2021-Q2
Decreased
1,200
-91.5%
$25,0000.0%$19.72
0
2021-Q1
Increased
14,122
+662.9%
$280,0000.0%$19.24
38
2020-Q4
Increased
1,851
+825.5%
$35,0000.0%$18.94
22
2020-Q3
Decreased
200
-82.7%
$5,0000.0%$25.45
0
2020-Q2
New
1,159
-
$35,0000.0%$30.45
30

Other major holders of RCEL: BlackRock Finance, Inc., BlackRock, Inc., Steward Partners Investment Advisory, LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used